Citronellyl cinnamate



Compound IDCDAMM01001
Common nameCitronellyl cinnamate
IUPAC name3,7-dimethyloct-6-enyl 3-phenylprop-2-enoate
Molecular formulaC19H26O2

Experimental data

Retention time16.94
Adduct[2M+H]+
Actual mz573.386
Theoretical mz573.393
Error12.17
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.0775

Identifiers and class information

Inchi keyKMXKQELDKDGFRN-OUKQBFOZNA-N
SmilesO=C(OCCC(C)CCC=C(C)C)C=CC=1C=CC=CC1
SuperclassLipids and lipid-like molecules
ClassFatty Acyls

Pharmacokinetic properties

Number of descriptor values(#stars)2
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)9
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)286.413
Computed dipole moment(dipole)3.263
Total solvent accessible surface area (SASA)686.75
Hydrophobic component of SASA (FOSA)385.519
Hydrophilic component of SASA (FISA)62.317
Pie component of the SASA (PISA)238.915
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1156.51
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)2
Free energy of solvation of dipole (dip^2/V)0.009207
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.775887
Predicted polarizability in cubic angstroms (QPpolrz)36.632
Predicted hexadecane/gas partition coefficient (QPlogPC16)11.133
Predicted octanol/gas partition coefficient (QPlogPoct)12.501
Predicted water/gas partition coefficient (QPlogPw)3.406
Predicted octanol/water partition coefficient (QPlogPo/w)5.715
Predicted aqueous solubility (QPlogS)-6.719
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.587
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.298
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)2540.7
Predicted brain/blood partition coefficient (QPlogBB)-0.669
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1355.36
Predicted skin permeability, log Kp (QPlogKp)-0.962
PM3 calculated ionization potential (IP(ev))9.464
PM3 calculated electron affinity (EA(eV))0.78
Number of likely metabolic reactions (#metab)3
Prediction of binding to human serum albumin (QPlogKhsa)1.058
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)37.096
Number of nitrogen and oxygen atoms (#NandO)2
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q8TDS4HCAR2Hydroxycarboxylic acid receptor 2T88185SEA
P02766TTRTransthyretinT86462SEA
Q96RI1NR1H4Bile acid receptor FXRT51426SEA
P43166CA7Carbonic anhydrase VIIT37541SEA
P23280CA6Carbonic anhydrase VIT06569SEA
Q9ULX7CA14Carbonic anhydrase XIVT31992SEA
P27338MAOBMonoamine oxidase BT83011SEA
P39086GRIK1Glutamate receptor ionotropic kainate 1T73495SEA
Q13002GRIK2Glutamate receptor ionotropic kainate 2T58178SEA
P15121AKR1B1Aldose reductaseT26623SEA
P42330AKR1C3Aldo-keto-reductase family 1 member C3T60857SEA
P18031PTPN1Protein-tyrosine phosphatase 1BT16347SwissTargetPrediction
P06746POLBDNA polymerase beta (by homology)T06958SwissTargetPrediction
P09917ALOX5Arachidonate 5-lipoxygenaseT00140SEA
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
P25116F2RProteinase-activated receptor 1T36483SEA
P19438TNFRSF1ATumor necrosis factor receptor R1T86552SEA
P21462FPR1Formyl peptide receptor 1T87831SEA
O75884RBBP9Putative hydrolase RBBP9T12084SEA
P21757MSR1Macrophage scavenger receptor types I and IIT50007SEA
Q9BY41HDAC8Histone deacetylase 8T28887SEA
P04632CAPNS1HUMAN calpain-1 or calpain small subunit 1 heterodimerT00099SEA
P01100FOSProto-oncogene c-FosT28025SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T88185DI0203Inborn lipid metabolism error[ICD-11: 5C52]Q8TDS4HCAR2
T86462DI0026Amyloidosis[ICD-11: 5D00]P02766TTR
T51426DI0043Autoimmune liver disease[ICD-11: DB96]Q96RI1NR1H4
T51426DI0077Cholelithiasis[ICD-11: DC11]Q96RI1NR1H4
T51426DI0320Osteoarthritis[ICD-11: FA00-FA05]Q96RI1NR1H4
T06569DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P23280CA6
T06569DI0372Seborrhoeic dermatitis[ICD-11: EA81]P23280CA6
T31992DI0046Bacterial infection[ICD-11: 1A00-1C4Z]Q9ULX7CA14
T31992DI0204Inborn metabolism deficiency[ICD-11: 5C50-5C59]Q9ULX7CA14
T83011DI0115Dementia[ICD-11: 6D80-6D8Z]P27338MAOB
T83011DI0117Depression[ICD-11: 6A70-6A7Z]P27338MAOB
T83011DI0190Hypertension[ICD-11: BA00-BA04]P27338MAOB
T83011DI0243Malaria[ICD-11: 1F40-1F45]P27338MAOB
T83011DI0264Migraine[ICD-11: 8A80]P27338MAOB
T83011DI0331Parkinsonism[ICD-11: 8A00]P27338MAOB
T73495DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]P39086GRIK1
T73495DI0396Substance abuse[ICD-11: 6C40]P39086GRIK1
T26623DI0298Neuropathy[ICD-11: 8C0Z]P15121AKR1B1
T26623DI0366Rheumatoid arthritis[ICD-11: FA20]P15121AKR1B1
T60857DI0145Female pelvic pain[ICD-11: GA34]P42330AKR1C3
T16347DI0009Acute diabete complication[ICD-11: 5A2Y]P18031PTPN1
T16347DI0062Breast cancer[ICD-11: 2C60-2C6Y]P18031PTPN1
T16347DI0308Obesity[ICD-11: 5B80-5B81]P18031PTPN1
T16347DI0417Type 2 diabetes mellitus[ICD-11: 5A11]P18031PTPN1
T06958DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P06746POLB
T00140DI0037Asthma[ICD-11: CA23]P09917ALOX5
T00140DI0147Filariasis[ICD-11: 1F66]P09917ALOX5
T00140DI0403Thrombocytopenia[ICD-11: 3B64]P09917ALOX5
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T36483DI0287Myocardial infarction[ICD-11: BA41-BA43]P25116F2R
T86552DI0060Brain cancer[ICD-11: 2A00]P19438TNFRSF1A
T86552DI0321Ovarian cancer[ICD-11: 2C73]P19438TNFRSF1A
T87831DI0333Peptic ulcer[ICD-11: DA61]P21462FPR1
T28887DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q9BY41HDAC8
T00099DI0106COVID-19[ICD-11: 1D6Y]P04632CAPNS1

Copyright © 2025